<p>Kempner Capital Management Inc. 在最近向证券交易委员会提交的 13F 表格中披露，在第四季度将其在 CONMED Corporation (NYSE:CNMD - 免费报告) 的持股减少了 87.4%。该基金在此期间出售了 43,296 股后，持有该公司 6,258 股股票。根据其最近的 SEC 文件，Kempner Capital Management Inc. 在 CONMED 的持股价值为 252,000 美元。</p>
<ul>
<li>医疗科技股 Conmed 在大规模第四季度报告前下跌……机会？</li>
</ul>
<p>其他对冲基金最近也对该公司的持仓进行了调整。Tributary Capital Management LLC 在第三季度新购入了价值 19,549,000 美元的 CONMED 股票。SG Americas Securities LLC 在第三季度将其在 CONMED 的持股增加了 3,041.3%。SG Americas Securities LLC 目前持有 63,894 股该公司的股票，价值 3,005,000 美元，此前在上个季度又购买了 61,860 股。Envestnet Asset Management Inc. 在第三季度将其在 CONMED 的持股增加了 31.9%。Envestnet Asset Management Inc. 目前持有 168,380 股该公司的股票，价值 7,919,000 美元，此前在此期间又购买了 40,697 股。Segall Bryant &amp; Hamill LLC 在第二季度新购入了价值 1,397,000 美元的 CONMED 股票。最后，Fisher Asset Management LLC 在第三季度将其在 CONMED 的持股增加了 9.3%。Fisher Asset Management LLC 目前持有 397,046 股该公司的股票，价值 18,673,000 美元，此前在上个季度又购买了 33,725 股。</p>
<h2>CONMED 价格表现</h2>
<p>CNMD 股票周三开盘价为 36.51 美元。该公司的速动比率为 1.01，流动比率为 2.14，债务与股本比率为 0.81。CONMED Corporation 的 52 周低点为 35.37 美元，52 周高点为 61.25 美元。该股票的 50 日移动平均线为 40.96 美元，200 日移动平均线为 43.33 美元。该公司的市值为 11.3 亿美元，市盈率为 24.18，市盈增长比率为 1.61，贝塔值为 0.91。</p>
<p>CONMED (NYSE:CNMD - 获取免费报告) 最近于 1 月 28 日星期三发布了其财报。该公司报告本季度每股收益为 1.43 美元，超出市场共识预期的 1.32 美元，超出幅度为 0.11 美元。CONMED 的股本回报率为 14.23%，净利润率为 3.42%。该公司本季度的收入为 3.732 亿美元，而分析师预期为 3.6688 亿美元。在去年同期，该公司每股收益为 1.34 美元。该公司的收入同比增长了 7.9%。分析师预测 CONMED Corporation 本财年每股收益将达到 4.35 美元。</p>
<h2>分析师设定新目标价</h2>
<p>多位分析师对 CNMD 股票发表了评论。Zacks Research 在 2 月 3 日的研究报告中将 CONMED 的评级从 “强烈卖出” 上调至 “持有”。Wells Fargo &amp; Company 在 3 月 18 日的研究报告中将 CONMED 股票的评级上调至 “持有”。Wall Street Zen 在一份研究报告中将 CONMED 的评级从 “强烈买入” 下调至 “买入”。Needham &amp; Company LLC 在 1 月 29 日的报告中重申了对 CONMED 股票的 “持有” 评级。最后，Weiss Ratings 在 1 月 21 日的研究报告中重申了对 CONMED 股票的 “卖出 (d+)” 评级。七位投资分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “减持”，平均目标价为 50.17 美元。</p>
<p><strong>查看我们关于 CONMED 的最新研究报告</strong></p>
<h2>关于 CONMED</h2>
<p>(免费报告)</p>
<p>CONMED Corporation NYSE: CNMD 是一家总部位于纽约尤蒂卡的全球医疗技术公司。成立于 1970 年，CONMED 开发、制造并销售广泛的外科设备和配件，专用于微创手术。该公司的产品线支持外科医生和医疗服务提供者在骨科、普通外科、胃肠病学和妇科等专业领域的工作。</p>
<p>CONMED 运营两个主要部门：骨科和可视化与能源。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，胜过 CONMED</li>
</ul>
<p><strong>想看看其他对冲基金持有的 CNMD 股票吗？</strong> 请访问 HoldingsChannel.com 获取 CONMED Corporation (NYSE:CNMD - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOTUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOTUQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CONMED 吗？</h2>
<p>在考虑投资 CONMED 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 CONMED 并不在名单上。</p>
<p>虽然 CONMED 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

康美公司

<p>Kempner Capital Management Inc. 在第四季度大幅减少了对 CONMED Corporation (NYSE:CNMD) 的持股，减持幅度达到 87.4%，目前持有 6,258 股，价值 252,000 美元。其他对冲基金也调整了其持仓，其中 Tributary Capital Management 和 SG Americas Securities 的增持尤为显著。CONMED 的股票开盘价为 36.51 美元，市值为 11.3 亿美元，市盈率为 24.18。分析师对该股票的评级意见不一，普遍评级为 “减持”，平均目标价为 50.17 美元</p>

<p>Kempner Capital Management Inc. reduced its stake in CONMED Corporation (NYSE:CNMD - Free Report) by 87.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities &amp; Exchange Commission. The fund owned 6,258 shares of the company's stock after selling 43,296 shares during the period. Kempner Capital Management Inc.'s holdings in CONMED were worth $252,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Kempner Capital Management Inc. 在最近向证券交易委员会提交的 13F 表格中披露，在第四季度将其在 CONMED Corporation (NYSE:CNMD - 免费报告) 的持股减少了 87.4%。该基金在此期间出售了 43,296 股后，持有该公司 6,258 股股票。根据其最近的 SEC 文件，Kempner Capital Management Inc. 在 CONMED 的持股价值为 252,000 美元。</p>
</div><ul>
<li>Med-tech stock Conmed dips ahead of big Q4 report...opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗科技股 Conmed 在大规模第四季度报告前下跌……机会？</li>
</ul>
</div><p>Other hedge funds also recently made changes to their positions in the company. Tributary Capital Management LLC acquired a new position in shares of CONMED in the 3rd quarter valued at $19,549,000. SG Americas Securities LLC raised its holdings in CONMED by 3,041.3% during the third quarter. SG Americas Securities LLC now owns 63,894 shares of the company's stock worth $3,005,000 after purchasing an additional 61,860 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of CONMED by 31.9% in the 3rd quarter. Envestnet Asset Management Inc. now owns 168,380 shares of the company's stock valued at $7,919,000 after buying an additional 40,697 shares during the period. Segall Bryant &amp; Hamill LLC acquired a new stake in CONMED in the second quarter valued at $1,397,000. Finally, Fisher Asset Management LLC boosted its holdings in CONMED by 9.3% during the third quarter. Fisher Asset Management LLC now owns 397,046 shares of the company's stock worth $18,673,000 after buying an additional 33,725 shares in the last quarter.</p>
<div class="lb-trans"><p>其他对冲基金最近也对该公司的持仓进行了调整。Tributary Capital Management LLC 在第三季度新购入了价值 19,549,000 美元的 CONMED 股票。SG Americas Securities LLC 在第三季度将其在 CONMED 的持股增加了 3,041.3%。SG Americas Securities LLC 目前持有 63,894 股该公司的股票，价值 3,005,000 美元，此前在上个季度又购买了 61,860 股。Envestnet Asset Management Inc. 在第三季度将其在 CONMED 的持股增加了 31.9%。Envestnet Asset Management Inc. 目前持有 168,380 股该公司的股票，价值 7,919,000 美元，此前在此期间又购买了 40,697 股。Segall Bryant &amp; Hamill LLC 在第二季度新购入了价值 1,397,000 美元的 CONMED 股票。最后，Fisher Asset Management LLC 在第三季度将其在 CONMED 的持股增加了 9.3%。Fisher Asset Management LLC 目前持有 397,046 股该公司的股票，价值 18,673,000 美元，此前在上个季度又购买了 33,725 股。</p>
</div><h2>CONMED Price Performance</h2>
<div class="lb-trans"><h2>CONMED 价格表现</h2>
</div><p>CNMD stock opened at $36.51 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 2.14 and a debt-to-equity ratio of 0.81. CONMED Corporation has a 52-week low of $35.37 and a 52-week high of $61.25. The stock's 50 day moving average is $40.96 and its two-hundred day moving average is $43.33. The company has a market capitalization of $1.13 billion, a PE ratio of 24.18, a P/E/G ratio of 1.61 and a beta of 0.91.</p>
<div class="lb-trans"><p>CNMD 股票周三开盘价为 36.51 美元。该公司的速动比率为 1.01，流动比率为 2.14，债务与股本比率为 0.81。CONMED Corporation 的 52 周低点为 35.37 美元，52 周高点为 61.25 美元。该股票的 50 日移动平均线为 40.96 美元，200 日移动平均线为 43.33 美元。该公司的市值为 11.3 亿美元，市盈率为 24.18，市盈增长比率为 1.61，贝塔值为 0.91。</p>
</div><p>CONMED (NYSE:CNMD - Get Free Report) last released its earnings results on Wednesday, January 28th. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.32 by $0.11. CONMED had a return on equity of 14.23% and a net margin of 3.42%.The company had revenue of $373.20 million during the quarter, compared to analysts' expectations of $366.88 million. During the same period in the prior year, the business posted $1.34 EPS. The business's revenue was up 7.9% on a year-over-year basis. Analysts predict that CONMED Corporation will post 4.35 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CONMED (NYSE:CNMD - 获取免费报告) 最近于 1 月 28 日星期三发布了其财报。该公司报告本季度每股收益为 1.43 美元，超出市场共识预期的 1.32 美元，超出幅度为 0.11 美元。CONMED 的股本回报率为 14.23%，净利润率为 3.42%。该公司本季度的收入为 3.732 亿美元，而分析师预期为 3.6688 亿美元。在去年同期，该公司每股收益为 1.34 美元。该公司的收入同比增长了 7.9%。分析师预测 CONMED Corporation 本财年每股收益将达到 4.35 美元。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>A number of analysts have commented on CNMD shares. Zacks Research upgraded CONMED from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, February 3rd. Wells Fargo &amp; Company raised shares of CONMED to a &#34;hold&#34; rating in a research note on Wednesday, March 18th. Wall Street Zen lowered CONMED from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research note on Saturday. Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of CONMED in a report on Thursday, January 29th. Finally, Weiss Ratings reaffirmed a &#34;sell (d+)&#34; rating on shares of CONMED in a research note on Wednesday, January 21st. Seven investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of &#34;Reduce&#34; and an average price target of $50.17.</p>
<div class="lb-trans"><p>多位分析师对 CNMD 股票发表了评论。Zacks Research 在 2 月 3 日的研究报告中将 CONMED 的评级从 “强烈卖出” 上调至 “持有”。Wells Fargo &amp; Company 在 3 月 18 日的研究报告中将 CONMED 股票的评级上调至 “持有”。Wall Street Zen 在一份研究报告中将 CONMED 的评级从 “强烈买入” 下调至 “买入”。Needham &amp; Company LLC 在 1 月 29 日的报告中重申了对 CONMED 股票的 “持有” 评级。最后，Weiss Ratings 在 1 月 21 日的研究报告中重申了对 CONMED 股票的 “卖出 (d+)” 评级。七位投资分析师对该股票给予了 “持有” 评级，一位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，该股票目前的共识评级为 “减持”，平均目标价为 50.17 美元。</p>
</div><p><strong>View Our Latest Research Report on CONMED</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CONMED 的最新研究报告</strong></p>
</div><h2>About CONMED</h2>
<div class="lb-trans"><h2>关于 CONMED</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>CONMED Corporation NYSE: CNMD is a global medical technology company headquartered in Utica, New York. Founded in 1970, CONMED develops, manufactures and markets a broad portfolio of surgical devices and accessories for minimally invasive procedures. The company's product line supports surgeons and healthcare providers in specialties including orthopedics, general surgery, gastroenterology and gynecology.</p>
<div class="lb-trans"><p>CONMED Corporation NYSE: CNMD 是一家总部位于纽约尤蒂卡的全球医疗技术公司。成立于 1970 年，CONMED 开发、制造并销售广泛的外科设备和配件，专用于微创手术。该公司的产品线支持外科医生和医疗服务提供者在骨科、普通外科、胃肠病学和妇科等专业领域的工作。</p>
</div><p>CONMED operates two principal segments: Orthopedics, and Visualization &amp; Energy.</p>
<div class="lb-trans"><p>CONMED 运营两个主要部门：骨科和可视化与能源。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than CONMED</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 CONMED</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CNMD?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CONMED Corporation (NYSE:CNMD - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 CNMD 股票吗？</strong> 请访问 HoldingsChannel.com 获取 CONMED Corporation (NYSE:CNMD - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOTUQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CNMD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CONMED Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CONMED 吗？</h2>
</div><p>Before you consider CONMED, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 CONMED 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CONMED wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 CONMED 并不在名单上。</p>
</div><p>While CONMED currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CONMED 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Kempner Capital Management Inc. 出售了康美公司 $CNMD 的股份